Langerhans-cell histiocytosis 'insight into DC biology'
Jon D Laman1, Pieter J M Leenen, Nicola E Annels
1Department of Immunology, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands.
Insights
Langerhans-cell histiocytosis (LCH) involves abnormal dendritic cell (DC) growth. This condition uniquely blends cancer-like and inflammatory features due to aberrant immune cell interactions.
Area of Science:
- Immunology
- Cell Biology
- Pathology
Background:
- Langerhans-cell histiocytosis (LCH) is characterized by uncontrolled proliferation of dendritic cells (DCs) with Langerhans-cell (LC) features.
- LCH cells exhibit immature, partially activated states and aberrant cell division regulation.
- The lesional microenvironment shows high cytokine production and unique chemokine/chemokine receptor patterns.
Purpose of the Study:
- To elucidate the immunological underpinnings of Langerhans-cell histiocytosis.
- To understand the aberrant interactions between LCH cells, T cells, and the microenvironment.
- To explore the combined features of carcinogenesis and chronic inflammation in LCH pathology.
Main Methods:
- Analysis of LCH cell characteristics, including activation state and cell division.
- Investigation of cytokine and chemokine profiles within LCH lesions.
- Examination of immune cell interactions, particularly involving T cells.
Main Results:
- LCH cells are arrested in an immature, partially activated stage with deviant cell division.
- High levels of diverse cytokines are produced, and specific chemokine patterns are observed.
- Aberrant immune interactions, driven by clonal DC changes, contribute to LCH pathology.
Conclusions:
- LCH pathology results from clonal DC changes leading to aberrant immune interactions.
- The disease presents a unique combination of neoplastic and chronic inflammatory characteristics.
- Understanding these mechanisms is crucial for LCH pathogenesis and potential therapeutic strategies.
Abstract:
Langerhans-cell histiocytosis (LCH) is caused by an uncontrolled pathogenic clonal proliferation of dendritic cells (DCs) with Langerhans-cell (LC) characteristics. LCH cells are arrested in an immature, partially activated stage and show a deviant regulation of cell division. Their aberrant interactions with T cells and the lesional microenvironment are typified by high level production of diverse cytokines. Chemokine and chemokine receptor patterns probably explain LCH predilection sites and lesion composition, reminiscent of chronic granulomatous inflammation. Recent advances in LCH immunology suggest that clonal changes in DCs might underlie the aberrant immune interaction with T cells, leading to a unique pathological picture, which combines features of carcinogenesis and chronic inflammation.
